10

SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on

  • Upload
    ngotu

  • View
    218

  • Download
    0

Embed Size (px)

Citation preview

Page 1: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 2: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 3: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 4: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 5: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 6: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 7: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 8: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 9: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on
Page 10: SOP version 4-12-18.pdf · The MDGs must maintain a list of disease-specific clinical trials segmented by disease specific criteria. The disease map must be reviewed and updated on